HTGM - HTG Molecular Diagnostics Inc. (HTGM) CEO John Lubniewski on Q2 2021 Results - Earnings Call Transcript
HTG Molecular Diagnostics, Inc. (HTGM) Q2 2021 Earnings Conference Call August 12, 2021 16:30 ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Rick Miller - Cantor Fitzgerald Alex Nowak - Craig-Hallum Presentation Operator Greetings, and welcome to HTG Molecular Diagnostics' Second Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] I would now like to turn this conference over to your host, Ms. Monique Kosse, LifeSci Advisors. Thank you ma'am. You may begin your presentation. Monique Kosse Thank you, Operator. Earlier today, HTG released its financial results for the second quarter ended June 30, 2021. Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws.
For further details see:
HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2021 Results - Earnings Call Transcript